Association of circulating PCSK9 concentration with cardiovascular metabolic markers and outcomes in stable coronary artery disease patients with or without diabetes: a prospective, observational cohort study

BACKGROUND: Whether plasma proprotein convertase subtilisin/kexin type 9 (PCSK9) levels is a predictor for cardiovascular outcomes has currently been controversial. No data is currently available regarding the relation of PCSK9 to cardiovascular metabolic markers (CVMMs) and major adverse cardiovasc...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Jia, Liu, Ming-Ming, Jin, Jing-Lu, Cao, Ye-Xuan, Guo, Yuan-Lin, Wu, Na-Qiong, Zhu, Cheng-Gang, Dong, Qian, Sun, Jing, Xu, Rui-Xia, Li, Jian-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541318/
https://www.ncbi.nlm.nih.gov/pubmed/33023603
http://dx.doi.org/10.1186/s12933-020-01142-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7541318/
https://www.ncbi.nlm.nih.gov/pubmed/33023603
http://dx.doi.org/10.1186/s12933-020-01142-0

Ejemplares similares